Upstream Processing
-
How To Use The CTS DynaCellect Bead Removal Kit
6/9/2025
Master the setup process for automated immune cell depletion workflows. This instructional overview covers essential installation steps, from sterile welding and tube routing to sensor alignment.
-
Rapid Process Development And Technical Support For AAV Scaleup
12/17/2024
Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.
-
CHO Solutions Day Part 1
5/29/2025
This CHO Solutions Day presentation offers valuable insights into new media and feed systems, a successful scale-up story, and how multi-omics analysis can enhance your cell culture.
-
Thermo Fisher Scientific Single-Use Global Manufacturing Network
4/18/2022
We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.
-
Thermo Fisher Scientific Bio-Expo Live 2024: Upstream Bioprocessing: A Next-Gen Medium And Feed System
8/15/2024
This presentation reviews next-generation cell culture media and feed options and a recent successful scale-up case study done in collaboration with Centre for Biochemical Engineering and Cell Cultivation Techniques at the Zurich University of Applied Sciences.
-
Advances In Custom Medium Development: The Multi-Omics Difference
6/9/2025
Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.
-
Addressing Post-Translational Modifications In Novel Protein Therapeutics
9/13/2024
Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.
-
Dry Powder Media Manufacturing Grand Island Expansion
11/5/2025
Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.
-
An Active Release Mechanism For Magnetic Separation And Cell Isolation
11/13/2023
Discover an innovative active release solution that will serve autologous and allogeneic processes to the benefit of cell therapy patients.
-
Rethinking Sustainability In Bioprocessing
5/22/2025
Discover how sustainability is transforming bioprocessing through innovative single-use technologies that help reduce environmental impact and support responsible, forward-thinking biomanufacturing.